Cite
Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs.
MLA
Roskoski, Robert, Jr. “Cyclin-Dependent Protein Serine/Threonine Kinase Inhibitors as Anticancer Drugs.” Pharmacological Research, vol. 139, Jan. 2019, pp. 471–88. EBSCOhost, https://doi.org/10.1016/j.phrs.2018.11.035.
APA
Roskoski, R., Jr. (2019). Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs. Pharmacological Research, 139, 471–488. https://doi.org/10.1016/j.phrs.2018.11.035
Chicago
Roskoski, Robert, Jr. 2019. “Cyclin-Dependent Protein Serine/Threonine Kinase Inhibitors as Anticancer Drugs.” Pharmacological Research 139 (January): 471–88. doi:10.1016/j.phrs.2018.11.035.